• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Upcoming Earnings Report Might Change The Case For Investing In Cardinal Health Stock (CAH)

    Simply Wall St·10/23/2026 12:38:24
    Listen to the news
    • Cardinal Health is preparing to release earnings in early November 2026. Forecasts point to higher earnings per share and revenue than the prior year, putting a spotlight on execution in Global Medical Products and Distribution and other higher margin services.
    • The business is working to tilt its mix toward steadier earnings from specialty distribution, at home chronic care and Biopharma Solutions while keeping product recalls and quality controls tightly managed.
    • We will now look at how Cardinal Health's upcoming earnings update could reshape its investment narrative around higher margin services.

    Compare Cardinal Health's setup ahead of earnings with other potential steady earners in healthcare by scanning our hand picked list of solid balance sheet and fundamentals (26 results).

    Cardinal Health Investment Narrative Recap

    To own Cardinal Health, you need to believe the mix shift toward specialty pharma distribution, Global Medical Products and Distribution, at Home Solutions and Biopharma Solutions can translate into steadier earnings, even with thin net margins of 0.7%. The upcoming November earnings update puts execution under a microscope, especially around higher margin services and cost control.

    The core near term catalyst is clean, consistent delivery from Global Medical Products and Distribution while product quality issues stay contained and do not expand beyond the levothyroxine recalls already disclosed. The biggest current risk remains any escalation of quality or regulatory actions that could strain customer relationships and compress profitability.

    The raised attention ahead of the November 5 earnings release, including the higher price target from Mizuho and recent share price momentum, ties directly into these execution questions. Analyst optimism only matters to you if management keeps scaling specialty distribution and services without letting quality slip or letting debt levels become a drag.

    For readers, the interesting tension is that forecasts still call for earnings growth of about 15% a year while the stock already trades on a P/E of 34.5%, above both peers and an estimated fair P/E of 31.6x. That combination puts even more weight on this earnings print as a proof point on margins, product controls and cash generation.

    Cardinal Health Earnings Setup Through 2029

    Cardinal Health's narrative projects US$297.6b revenue and US$3.0b earnings by 2029. This rests on analysts assuming 5.4% yearly revenue growth and an earnings increase of about US$1.3b from US$1.7b today.

    Uncover why Cardinal Health's fair value indicates a 6% potential upside to its current price that could narrow quickly.

    NYSE:CAH 1-Year Stock Price Chart
    NYSE:CAH 1-Year Stock Price Chart

    Exploring Other Perspectives

    Three fair value estimates from the Simply Wall St Community stretch from about US$270.94 to US$741.95 per share, a very wide band that shows how far opinions on Cardinal Health can spread. When you set that against recall risk, insider selling and input cost pressure, you get plenty of reasons to compare multiple viewpoints before committing fresh capital.

    Explore 2 other Cardinal Health fair value estimates, including one that suggests potential upside of as much as 190% from the current price.

    The Verdict Is Yours

    Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.

    Looking For More Ideas Beyond Cardinal Health?

    If you want a broader watchlist alongside Cardinal Health, it can help to scan for companies that already meet some of the quality, income or valuation traits you care about. The Simply Wall St Screener lets you filter for these types of opportunities in a few clicks.